Will iPS Cells Enhance Therapeutic Applicability of Cord Blood Cells and Banking?

Research output: Contribution to journalArticle

33 Citations (Scopus)

Abstract

The exciting development of induced pluripotent stem cells (iPSCs), and the discovery that iPSCs can be derived from cord blood (CB), combined with the presence of nonhematopoietic stem and progenitor cells in CB may lead to enhanced therapeutic applicability of this cell source and induce increased CB banking.

Original languageEnglish
Pages (from-to)21-24
Number of pages4
JournalCell Stem Cell
Volume6
Issue number1
DOIs
StatePublished - Jan 8 2010

Fingerprint

Blood Banks
Fetal Blood
Induced Pluripotent Stem Cells
Blood Cells
Stem Cells
Therapeutics

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Medicine
  • Genetics

Cite this

Will iPS Cells Enhance Therapeutic Applicability of Cord Blood Cells and Banking? / Broxmeyer, Hal.

In: Cell Stem Cell, Vol. 6, No. 1, 08.01.2010, p. 21-24.

Research output: Contribution to journalArticle

@article{4ce6df2e4b94432e9f40b9e42e356649,
title = "Will iPS Cells Enhance Therapeutic Applicability of Cord Blood Cells and Banking?",
abstract = "The exciting development of induced pluripotent stem cells (iPSCs), and the discovery that iPSCs can be derived from cord blood (CB), combined with the presence of nonhematopoietic stem and progenitor cells in CB may lead to enhanced therapeutic applicability of this cell source and induce increased CB banking.",
author = "Hal Broxmeyer",
year = "2010",
month = "1",
day = "8",
doi = "10.1016/j.stem.2009.12.008",
language = "English",
volume = "6",
pages = "21--24",
journal = "Cell Stem Cell",
issn = "1934-5909",
publisher = "Cell Press",
number = "1",

}

TY - JOUR

T1 - Will iPS Cells Enhance Therapeutic Applicability of Cord Blood Cells and Banking?

AU - Broxmeyer, Hal

PY - 2010/1/8

Y1 - 2010/1/8

N2 - The exciting development of induced pluripotent stem cells (iPSCs), and the discovery that iPSCs can be derived from cord blood (CB), combined with the presence of nonhematopoietic stem and progenitor cells in CB may lead to enhanced therapeutic applicability of this cell source and induce increased CB banking.

AB - The exciting development of induced pluripotent stem cells (iPSCs), and the discovery that iPSCs can be derived from cord blood (CB), combined with the presence of nonhematopoietic stem and progenitor cells in CB may lead to enhanced therapeutic applicability of this cell source and induce increased CB banking.

UR - http://www.scopus.com/inward/record.url?scp=73049104550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=73049104550&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2009.12.008

DO - 10.1016/j.stem.2009.12.008

M3 - Article

C2 - 20074533

AN - SCOPUS:73049104550

VL - 6

SP - 21

EP - 24

JO - Cell Stem Cell

JF - Cell Stem Cell

SN - 1934-5909

IS - 1

ER -